Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.83 USD | +1.49% | +0.89% | -26.24% |
May. 10 | Wells Fargo Adjusts Price Target on Health Catalyst to $13 From $14, Keeps Overweight Rating | MT |
May. 09 | Health Catalyst Seeks M&A | CI |
Financials (USD)
Sales 2024 * | 308M | Sales 2025 * | 344M | Capitalization | 397M |
---|---|---|---|---|---|
Net income 2024 * | -58M | Net income 2025 * | -46M | EV / Sales 2024 * | 2.35 x |
Net Debt 2024 * | 327M | Net Debt 2025 * | 321M | EV / Sales 2025 * | 2.09 x |
P/E ratio 2024 * |
-7.15
x | P/E ratio 2025 * |
-9.75
x | Employees | 1,300 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.97% |
Latest transcript on Health Catalyst, Inc.
1 day | +1.49% | ||
1 week | +0.89% | ||
Current month | +9.81% | ||
1 month | +13.27% | ||
3 months | -16.30% | ||
6 months | -7.89% | ||
Current year | -26.24% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Burton
CEO | Chief Executive Officer | 49 | 11-08-31 |
Jason Alger
DFI | Director of Finance/CFO | 40 | 13-03-31 |
Jason Jones
CTO | Chief Tech/Sci/R&D Officer | - | 18-11-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Kane
CHM | Chairman | 71 | 15-11-14 |
Duncan Gallagher
BRD | Director/Board Member | 64 | 17-05-11 |
Anita Pramoda
BRD | Director/Board Member | 49 | 16-04-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 14 M€ | -4.84% | ||
0.05% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 6.83 | +1.49% | 290,845 |
24-05-24 | 6.73 | +1.20% | 468,771 |
24-05-23 | 6.65 | -2.92% | 357,083 |
24-05-22 | 6.85 | +1.18% | 364,382 |
24-05-21 | 6.77 | -2.10% | 327,201 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.24% | 397M | |
-19.81% | 213B | |
-21.96% | 58.61B | |
-2.23% | 58.3B | |
-13.57% | 45.97B | |
+0.60% | 41.34B | |
-3.48% | 36.11B | |
-9.59% | 28.91B | |
+108.86% | 27.03B | |
+2.63% | 21.91B |
- Stock Market
- Equities
- HCAT Stock